Company / SG&A per Share
Catalyst Pharmaceuticals Partners, Inc. SG&A per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$1.58
FY2025
5-year range
$0.48 / $1.58
FY2021-FY2025
Trend
+7.6%
vs FY2024
Sector context
#92 of 210
Health Care
What the data says
At $1.58, Catalyst Pharmaceuticals Partners, Inc.'s sg&a per share ranks #119 of 210 in the Health Care sector. SG&A per Share has increased for 9 consecutive years, from $0.10 in FY2016 to $1.58 in FY2025.
Based on SEC 10-K filings.
1.58 in FY2025 with a 5-year CAGR of +29.9%.
Increased from $1.25 to $1.58 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +42.9%
- 5-Year CAGR
- +29.9%
- 10-Year CAGR
- -
Sector benchmark
#119 of 210 in Health CareTop 56% of 210This company $1.58 Sector average $40.71
▼
-96.1% below sector average
Key checks
Key Insights
- Catalyst Pharmaceuticals Partners, Inc.'s sg&a per share has grown for 9 consecutive years.
- In FY2025, sg&a per share increased 7.6% year-over-year.
- Ranks #92 out of 210 companies in the Health Care sector.
- Lowest sg&a per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 4.78 (safe zone, above 2.9 threshold)
- Strong profit margin: 33.3%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.58 | +7.6% |
| FY2024 | $1.47 | +17.8% |
| FY2023 | $1.25 | +130.2% |
| FY2022 | $0.54 | +12.5% |
| FY2021 | $0.48 | +12.6% |
| FY2020 | $0.43 | +19.2% |
| FY2019 | $0.36 | +131.9% |
| FY2018 | $0.15 | +49.4% |
| FY2017 | $0.10 | +8.7% |
| FY2016 | $0.10 | -8.1% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026